In this study we describe the clinical, morphologic, immunologic, and genetic features of a chronic peripheral blood lymphocytosis associated with posttraumatic splenectomy in patients with human immunodeficiency virus-1 (HIV-1) infection. Among a series of 2,365 consecutive HIV-1 seropositive cases investigated, eight patients were selected for the presence of more than 4,000 lymphocytes/ mm3. All cases were characterized by a lymphocytosis with cytoplasmic azurophilic granules; in three patients the hematologic picture was superimposable with that of lymphoproliferative disease of granular lymphocytes.
Phenotypic analysis of lymphocytes showed a prevalent CD3+CD8+ pattern. In vitro evaluations, including the response to mitogens and interleukin-2 and the cytotoxic assays, showed an unimpaired lymphocyte function in the majority of our patients, even in those with advanced stages NFECTION with the human immunodeficiency virus-1 I (HIV-1) is associated with a progressive decline in the number and function of peripheral blood (PB) lymphocytes (mostly CD4+ cells) that contributes to the massive derangement of the immune system that characterizes the clinical picture of patients with acquired immunodeficiency syndrome (AIDS).'.' The hematologic complications, both neoplastic3 and non-neoplastic (anemia and thrombocyto~e n i a ) ?~ that may develop besides opportunist and nonopportunist infections are probably secondary to the HIV-1 -associated damage of the host immunocompetence.'S2 Although a progressive reduction of CD4' lymphocytes represents the hallmark of HIV-1 infection, a moderate increase of CD8" lymphocytes has been reported in the early phases of HIV-1 infection.6 This lymphocytosis is usually short-lasting and the number of CD8+ cells subsequently declines with the progressive depletion of CD4 lymphocytes. However, in some cases the persistence of a chronic lymphocytosis sustained by CD8+ lymphocytes has been reported in patients suffering from lymphocytic interstitial pneumonia~' or from the recently described diffuse infiltrative CD8 lymphocytosis syndrome. ' In this study, we describe a series of patients characterized by a persistent peripheral blood (PB) lymphocytosis associated with HIV-1 infection. They were selected from a group of 2,365 HIV-1-infected patients who were referred to our institutions between 1984 and 199 1. Interestingly, all cases under study had suffered from a posttraumatic splenectomy. Although in healthy individuals splenectomy on its own is accompanied by a moderate lymphocytosis, often associated with an increased granular lymphocyte (GL) count,' in our series of HIV-I-infected patients the evidence of a chronic lymphocytosis, even in the more advanced stages of disease, is unusual. This finding prompted us to investigate the morphologic, phenotypic, functional, and molecular features of PB lymphocytes of this series of patients, in an attempt to unravel the pathogenesis of this persistent lymphocytosis in HIV-1 -infected subjects and possibly define cases with a different prognosis.
of the syndrome. The analysis of the configuration of the T-cell receptor (TCR) B and y genes showed a polyclonal pattern of rearrangement. At the mean follow-up time of 45 f 8 months, one patient died of overdose when the clinical conditions were stable; all the other patients are alive, although disease progression was documented in two. Our results indicate that a chronic polyclonal lymphocytosis may be associated with HIV-1 infection; this finding seems to be restricted to patients who have undergone splenectomy. The demonstration of a still uncompromised immune system together with a silent clinical course in the patients under study also suggest that splenectomy per se does not favor an aggressive clinical behavior of HIV-1 infection.
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MATERIALS AND METHODS
Study populations. The criteria followed for including the patients in this study were the presence of a persistent PB lymphocytosis (more than 4,000 lymphocytes/mm' for more than 6 months) in patients with HIV-1 infection. Out of a series of 2,365 consecutive HIV-1-infected patients referred to our institutions, only 8 cases fulfilled the above quoted criteria. Quite surprisingly, all cases under study had suffered from a posttraumatic splenectomy, which was antecedent (range I month to 6 years) to the first evidence of HIV-I infection. In our series we were unable to detect any lymphocytosis with more than 4,000 lymphocytes/mm3 in cases that had not undergone splenectomy. The risk factors for HIV-I infection in the eight patients under study included intravenous (IV) drug abuse (n: 7) and posttransfusional HIV-I infection (n: I). According to the Centers for Disease Control (CDC) criteria for HIV-1 -related disorders, at the time of the first evaluation one patient (case 8) was asymptomatic (group 11), two patients (cases 2 and 6) showed persistent lymphoadenopathy without signs of progression (group 111), and five patients (cases 1, 3, 4, 5, and 7) had AIDS-related complex (group IV-A).
ZAMBELLO ET AL
Two cases (patients 4 and 5) had begun zidovudine (AZT) therapy 6 months before the first immunologic evaluation; the other patients were under no specific therapy. All patients were positive for antibodies to HIV-I both by enzyme-linked immunosorbent assay (ELISA) and by Western blot analysis. None had antibodies against human T-cell leukemia virus-1 (HTLV-1). The cutoff limit for the clinical follow-up was November 1992.
Four normal HIV-1 -negative individuals who had undergone a posttraumatic splenectomy more than 6 months before immunologic evaluation and 10 normal subjects were included for in vitro studies and referred to as controls A and B, respectively. Approval was obtained from the Institutional Review Board for these studies. Patients and volunteers were informed that blood samples were obtained for research purposes, and that their privacy would be protected. PB mononuclear cells (PBMC) were isolated on Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) gradient separation and washed twice in phosphate-buffered saline (PBS) according to the method previously reported." Morphologic analysis for evaluation of GL was performed on May-Griinwald Giemsastained cytospins. PBMC were studied for expression of cell-surface antigens with direct one-color or two-color analysis using a panel of fluorescein-conjugated (FITC) or phycoerythrin-conjugated (PE) mouse monoclonal antibody (MoAb), as previously reported." The following MoAbs were used anti-CD3 (OKT3), anti-CM (OKT4), and anti-CD8 (OKT8) purchased from Ortho Diagnostic (Raritan, NJ); anti-CD16 (Leu1 la), anti-CD56 (Leul9), and anti-CD57 (Leu7) purchased from Becton Dickinson (Sunnyvale, CA). The T-cell receptor-a (TCR-a)/&related TCRl (clone WT3 I; Becton Dickinson) and TCR-y/G-related TCR-y/G-1 (Becton Dickinson) MoAbs not classified in CD were also used. WT3 I reacts with a CD3 epitope usually associated with the a/@ TCR while TCR-yIG-1 MoAb reacts with a common epitope apparently expressed on all y/G cells. To characterize virgin and memory cells, CD45RA (Leul8; Becton Dickinson) and CD45RO (UCHLI; Dako, Glostrup, Denmark) MoAbs were used, respectively. AntLCD25 (B-B 10, IgG2a), which reacts with the p55 chain of interleukin-2 (IL-2) receptor (IL2R) and blocks IL-2 binding to this subunit, was a gift of Dr J. Wijdenes (Besancon, France);" ascitic fluid containing TU27 MoAb (I@ I), which reacts with the p75 molecule of I L 2 receptor and blocks IL-2 binding to this subunit," was a gift of Dr K. Sugamura (Tohoku, Japan) and Dr J. Hamuro (Senday, Japan). Because the expression of the p75 IL-2R on cell surface is faint, an amplification system consisting of a biotinilated second antibody (goat anti-mouse IgGI, Amersham International, Amersham, UK) and PE-conjugate strep tavidin (Becton Dickinson) was used." Cells were then analyzed using a FACScan analyzer (Becton Dickinson) and data were processed by using either FACScan Research and Consort 30 Software programs (Becton Dickinson). Ten thousand cells bearing the typical lymphocyte scatter were scored.
The cytotoxic activity was assessed on the basis of the lysis of 51Cr-labeled natural killer (NK)-sensitive K-562 and NK-resistant Raji target cells in a 4-hour assay, as previously reported.'I Lytic function of PBMC was analyzed both'at resting conditions and after in vitro activation of lymphocytes (106/mL) with 100 U/mL of recombinant IL-2 (Biogen, Cambridge, MA) or 500 ng/mL of anti-CD3 (OKT3) MoAb (Ortho Diagnostic) for 72 hours at 37°C in a 5% COz atmosphere. These times and doses provided optimum stimulation of control PBMC. Lectindependent-cell-mediated-cytotoxicity (LDCC) was evaluated at a 40: 1 effector to target ratio in the presence of phytohemoagglutinin (PHA) (I &mL hghly TCR gene analysis. DNA was extracted from PBMC and digested with the appropriate restriction enzymes, electrophoresed on 0.8% agarose gels, transferred to nitrocellulose paper, and hybridized with "P random-primed probes, as described previ0us1y.l~ Filters were washed under stringent conditions and autoradiographed. The TCR / 3 chain gene was analyzed by means of a 0.4-kb BglII cDNA hgment derived from the JUR-02 clone,I6 which codes for most of the Cp2 constant domains. The TCR y chain gene was investigated using a 0.7-kb HindIII-EcoRI fragment containing the joining (Jy I ) region, ahead of the Cy 1 segmentL7 Because of the sequence homology, the J y l probe detects also the Jy2 region.
In vivo response to tetanus toxoid. To test the in vivo immune status of splenectomized HIV-1 patients, in three representative cases (4, 5, and 7) we evaluated the specific antibody response after immunization with tetanus toxoid. After their informed consent, the patients were immunized with a single dose of tetanus toxoid (Bio Merieux, Lyon, France). As controls, three normal individuals indicated as A, B, and C from the lab staff were included in the study. All subjects had completed a regular cycle of antitetanus vaccination at least 5 years before the present study. Sera from each of these subjects were collected before and after 2 and 3 weeks from immunization and specific antibodies were detected with a commercially available hemoagglutination test, according to the manufacturer's instructions (ISM, Milan, Italy). The titration of sera under examination is indicated by the highest serum dilution still inducing hemoagglutination of tetanus toxoid-coated red blood cells (RBCs). A titration of 1: 1,024 corresponds to 0.1 International Antitoxic Units (IAU)/mL. An increase of specific antitetanus toxoid antibody titration up to or higher than three dilutions was accepted as significant.
Data are expressed as mean f SD and comparisons between values were made using the Cochran-Cox analysis. A P value i .05 was considered as significant.
Statistical analysis.

RESULTS
T h e median duration of follow-up per patient was 45 * 8 months (range 29 to 54 months) with persistence of lymphocytosis. A consistent increase of GL was shown in all patients with respect to controls (range 990 GL/mm3 to 4,890 GL/mm3 v 860 GL/mm3 to 1,430 GL/ mm3, respectively) ( Table 1) . Three cases (patients 1, 2, and 3 j were characterized by the prolonged presence of more than 2,000 circulating GL/mm3, which allowed a diagnosis of lymphoproliferative disease o f G L to be made.18J9 One patient (case 2) died of a n overdose after 38 months of follow-up when the clinical course of HIV-1 infection was stable. The clinical and laboratory parameters remained stable i n all but two cases (patients 1 and 7) i n whom a progression of disease was recorded during the follow-up period. After a 2 1-month Clinical course.
For 
Abbreviation: ND, not determined.
More than 90% of CD3 lymphocytes expressed an a/@ TCR (WT31+ MoAb), whereas y/6 TCR (TCR-y/6-1 + MoAb)-bearing cells represented t Controls A refer to HIV-1 negative individuals who underwent a posttraumatic splenectomy; controls B refer to unsplenectomized healthy subjects.
1 % to 8% of CD3+ lymphocytes.
follow-up, patient 1 developed a systemic episode of visceral candidiasis (IVC I, according to the CDC stage system) with good response to antifungal therapy. Disease progression was documented in patient 7 on the basis of development of oral candidiasis that occurred after an 18 month follow-up (IVC2, according to the CDC stage system). Anemia (hemoglobin (Hb) < 11 g/dL) or thrombocytopenia (platelets < 100 X 103/mm3) were not present. None of the patients developed Kaposi sarcoma. As shown in Table 1 , the CD3+CD8+ was the prevalent phenotype expressed by the patients' lymphocytes, with the exception of case 8, in whom a normal CD4/CD8 ratio was present. The majority of cells expressed the alp TCR; less than 8% of the cells showed a y/6 TCR (data not shown). The CD16, CD56, and CD57 NK-related markers were heterogeneously expressed. A high percentage of lymphocytes expressed the activation-associated antigen HLA-DR and the p75 chain of the IL2R, whereas the p55 IL-2R chain was never detected on the surface of cells under study. Double-staining analysis showed that the HLA-DR and the p75 IL-2R were mostly coexpressed by CD8+ cells. Using this methodological approach we also showed that the majority of PB CD8 lymphocytes expressed the CD45RA antigen.
Cytotoxic activity against K-562 target cells was investigated in 7 of 8 cases (case 2 was not tested). All patients but 2 (cases 4 and 7) showed cytotoxic values within the control range (1 8 to 30 LU; mean in controls 24 LU +-7). In patient 8, PBMC were tested only at resting conditions and showed normal values of cytotoxicity against the K-562 target (22 LU). Activation with anti-CD3 and IL-2 increased the cytotoxicity in all samples tested. LDCC was evaluated in six cases and the values were considered within the control range in four. Interestingly, both patients with low-spontaneous cytotoxicity showed normal lectin-mediated lysis of K-562 cells. None of the patients exhibited spontaneous lytic activity against the Raji targets (Table 2) . After activation with IL2, in the majority of cases the lymphocytes Phenotypic analysis.
Cytotoxic activity.
developed lymphokine killer activity (LAK); the values obtained, however, were lower than those observed using control lymphocytes.
The ability of PBMC to proliferate after PHA, anti-CD3, and IG2 stimulation was evaluated in six patients (Table 3 ). An impaired response to PHA was shown in 1 of the 5 cases tested on the other hand, all six cases showed a reduced cell-proliferative response to anti-CD3 MoAb, as compared with control values (P < .001). A significant proliferative response to IL-2 was documented in all cases (range 5,061 cpm to 19,584 cpm).
Effect of anti-ILL-2R p55 and p75 MoAbs on the IL-2-dependent proliferative activity. The proliferative activity after stimulation of PBMC with IL-2 was slightly inhibited by the anti-Tac MoAb alone (9,670 cpm k 310 v 8,860 -t 300; P = not significant). By contrast, the anti-p75 IL9R TU27 MoAb showed a significant reduction of proliferative activity (2,430 cpm f 225) as compared with IG2 alone ( P Proliferative activity. < .01) and to IL-2 plus anti-p55 IL-2R MoAb (P < .OI). The combination of anti-p55 and anti-p75 IL-2R MoAbs completely blocked the IL-2-mediated proliferation.
As shown in Fig 1, a polyclonal rearrangement of cx/B and y/S TCR-chain genes was shown in all patients studied using both the CB2 and Jyl probes (panels A and B, respectively). In EcoRl digestion the CB probe shows a reduction in intensity of the 12.0-kb band in all lines; none of the samples presented new rearrangement bands. In Hind111 digestion, the Jyl probe hybridization shows a multiple band pattern in all cases; this configuration, because the comigration of identical Vy genes rearranged to the J elements, is indicative of a polyclonal pattern. A restriction fragment-length polymorphism is responsible of the lack of the 4.9-kb germ-line fragment in the control line C and in samples 2, 4, and 5.
As reported in Table 4 , HIV-1-splenectomized patients showed a significant response against tetanus toxoid boosting (three times more the specific antibody titration), and consistent to that of normal individuals. In fact, a progressive increase of antitetanus toxoid-specific antibody titration was documented in each patient, raising from values between I: 128 to 1: 1,024 before antitetanus toxoid boosting to values comprised between 1:4,096 to 1:8,192 after 3 weeks from antigen stimulation.
a/@ and y/6 TCR anal-vsis.
Specific in vivo response to tetanus toxoid.
DISCUSSION
In this study we describe a series of HIV-I-infected patients with a persistent lymphocytosis associated with a posttraumatic splenectomy. Morphologically, a marked increase in GL (more than 2,000/mm3), consistent with a diagnosis of lymphoproliferative disease of GL (LDGL)'8-20 was documented in 3 of the 8 cases. To the best of our knowledge only one case of LDGL (characterized by a proliferation of CD3-GL) has so far been reported in HIV-I-seropositive individuals?' the patients herein described are the first series of LDGL sustained by CD3' lymphocytes (CD3+ LDGL) associated with HIV-1 infection.
The clonal and likely neoplastic nature of the proliferating cells in LDGL has been reported in the majority of CD3' cases, as determined by the analysis of the TCR p and y gene c o n f i g~r a t i o n . '~.~~.~~ However, patients with a polyclonal rearrangement of the TCR / 3 and y genes have also been d o c~m e n t e d , '~* *~.~~*~~ reflecting the reactive nature of some LDGL. The polyclonal configuration of the TCR and y genes observed in all our patients (Fig 1) supports the putative reactive origin of their lymphocytosis. The hypothesis that For The value indicates the highest dilution of serum sample that show a positive reaction.
in these cases the LDGL could represent an immunologic in vivo response to infection by HIV-1 might be reasonably formulated, though other viruses must be taken into account, including Epstein-Barr, cytomegalovirus (CMV), and hepatitis B, which have been related to the pathogenesis of some LDGL'9,20 and commonly infect drug abusers.
To address the intriguing issue of the relevance of splenectomy to the immune functions in HIV-1 patients, we performed a series of in vitro and in vivo analyses. These data collectively suggest that immunologic responses of the patients' lymphocytes, even in those with more advanced stages of the syndrome, are still preserved. In fact, in terms of in vitro analysis, only 2 of 7 cases studied (patients 4 and 7) showed a reduced NK activity, and 1 case out of 5 (patient 1) showed an impaired proliferative response to PHA. In addition, in all cases tested the lymphocytes responded to IL-2 by increasing the proliferative activity and the cytotoxicity, and by developing the LAK function. As far as in vivo studies are concerned, we showed that the immunologic response against the tetanus toxoid in three cases was consistent with that observed in controls (Table 4) . Together with the overall immunologic analysis of patients hereby reported, these features also allow some considerations on the pathophysiology of the immune system in HIV-I infection.
Splenectomy is likely to represent the central event in the mechanisms accounting for the unusually high increase of lymphocytes (and GL) in the PB of the patients under study, as an absolute lymphocytosis has not been detected in other cases. A recent study reports a syndrome characterized by CD8 lymphocytosis associated with ~plenomegaly.~~ Consistent with this observation, posttraumatic splenectomy in our group of patients may have been precipitated by an already enlarged spleen occumng as a part of this syndrome. Because in our patients the splenectomy precedes the first detection of HIV-1 infection, the issue of whether the mechanism of CD8 lymphocytosis is one of decreased splenic sequestration or one intrinsic to the syndrome associated with splenomegaly still remains elusive. However, it should be pointed out that among the 2,365 patients included in this study, splenomegaly was not documented in any case. In Table 5 some distinctive features related to HIV-1 -associated lymphocytosis, postsplenectomy lymphocytosis, and LDGL are summarized.
The spleen represents a crucial site of immune responses and, notably, of lymphokine production during HIV-1 infection. It is worth considering that HIV-1 -infected children are not usually lymphopenic and the possibility that a putative immaturity of the spleen could be taken into account to explain this finding. However, this possibility seems rather unlikely because using the polymerase chain reaction (PCR), it has been shown that HIV-I DNA sequences were detected in 8 of 9 spleen samples of 16 to 24-week-old fetuses obtained from HIV-1-infected mothers." These findings suggest that spleen involvement in HIV-1 infection could take place from the first weeks of intrauterine life. A primary specific cytotoxic T-cell response against HIV-1 proteins has been detected in spleens from HIV-1 seropositive patients with idiopathic thrombocytopenic p~rpora,*~ suggesting that HIV-1-infected cells can be recognized and destroyed in the spleen. As indicated by several reports,'Y2 HIV-1 takes advantage of the normal immunologic processes through the infection of lymphoid and monocyte/macrophage cells spreading into the organism, and finally overcoming host resistance. A similar mechanism is likely to take place in the spleen microenvironment. In this respect, the removal of this relevant part of the immune system (ie, the spleen) may lead to a redistribution of immunecompetent cells in the PB, with two main consequences: on one hand, a reduced number of CD4+ cells For personal use only. on September 24, 2017. by guest www.bloodjournal.org From could possibly be infected by HIV-1 as the result of the lack of an important site of immune response, and thus little cellto-cell contact. On the other hand, a high number of CD8+ cytotoxic T-lymphocytes, possibly specific for HIV-1, could circulate in the PB. Both mechanisms could be claimed to explain the increased number of circulating lymphocytes. Further studies involving a larger number of such cases and facing the issue of the specificity of cytotoxic response are needed to validate these hypotheses.
Although an impaired IL-2 production and defects of the IL2-related functions have been reported in HIV-1 -infected the pathogenesis of these findings is not fully understood. We have herein shown that the pathways of IL-2 activation are not impaired in these patients and that the p75 IL-2R is involved in the process of signal transduction in the cells under study. In fact, the patients' lymphocytes expressed the intermediate affinity IL-2R chain while lacking the p55 chain of the IL-2R, furthermore, anti-p75 IL-2R TU27 MoAb was capable of blocking the IL-2-mediated cell activation.
The role ofthe spleen in HIV-1-infected subjects deserves a final comment because the relationship between splenectomy and disease progression in seropositive patients has not been completely elucidated. The progression to AIDS has been found to occur in about 50% of HIV-1 -infected patients within a period of about 10 years after seroconversion2* and this cutoff limit has not been reached by our patients (time elapsed from seroconversion ranged from 5 to 9 years). However, on the basis of the clinical and immunologic data of our patients, it may be suggested that splenectomy per se does not favor a more aggressive clinical course of HIV-1 infection than expected. This may be of practical interest because in the course of some clinical complications associated with HIV-1 infection, such as persistent thrombocytopenia, splenectomy has been proposed as an alternative therapeutic approach.29
